Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial von Spiridonidis, C.H., Laufman, L.R., Carman, L., Moore, T., Blair, S., Jones, J., George, Ch, Patel, T., Roach, R., Rupert, R., Zangmeister, J., Colborn, D., Kuebler, J.Ph

Volltext